• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重症监护中急性肾损伤的肾脏替代治疗

Renal replacement therapy for acute kidney injury in intensive care.

作者信息

Davies Thomas W, Ostermann Marlies, Gilbert-Kawai Edward

机构信息

ACCS Anaesthesia Speciality Trainee, Department of Critical Care, University College Hospital, London NW1 2BU.

Consultant in Nephrology and Intensive Care Medicine, Department of Critical Care, Guy's and St. Thomas' NHS Foundation Trust, London.

出版信息

Br J Hosp Med (Lond). 2019 Aug 2;80(8):C124-C128. doi: 10.12968/hmed.2019.80.8.C124.

DOI:10.12968/hmed.2019.80.8.C124
PMID:31437042
Abstract

Acute kidney injury is a common occurrence on the intensive care unit and is associated with incremental risk of death and chronic kidney disease. Renal replacement therapy has become an essential tool in the intensive care management of patients with severe acute kidney injury and its use is rising. A basic understanding of renal replacement therapy is essential for all doctors treating acutely unwell patients. This article provides a brief overview of the principles and important considerations for the provision of renal replacement therapy for critically ill patients with acute kidney injury.

摘要

急性肾损伤在重症监护病房很常见,并且与死亡风险增加及慢性肾脏病相关。肾脏替代治疗已成为重症急性肾损伤患者重症监护管理中的一项重要手段,其使用正在增加。对于所有治疗急性病患者的医生而言,对肾脏替代治疗有基本的了解至关重要。本文简要概述了为急性肾损伤重症患者提供肾脏替代治疗的原则及重要注意事项。

相似文献

1
Renal replacement therapy for acute kidney injury in intensive care.重症监护中急性肾损伤的肾脏替代治疗
Br J Hosp Med (Lond). 2019 Aug 2;80(8):C124-C128. doi: 10.12968/hmed.2019.80.8.C124.
2
Controversies Surrounding Renal Replacement Therapy in the Critically Ill Patient.危重症患者肾脏替代治疗的争议。
Semin Respir Crit Care Med. 2019 Oct;40(5):662-672. doi: 10.1055/s-0039-1697966. Epub 2019 Dec 11.
3
Risk Factors for Mortality in Critically Ill Children Requiring Renal Replacement Therapy.危重症儿童需要肾脏替代治疗的死亡风险因素。
Pediatr Crit Care Med. 2019 Nov;20(11):1069-1077. doi: 10.1097/PCC.0000000000002045.
4
Timing of continuous renal replacement therapy and mortality in critically ill children*.危重症儿童连续性肾脏替代治疗时机与死亡率的关系*。
Crit Care Med. 2014 Apr;42(4):943-53. doi: 10.1097/CCM.0000000000000039.
5
Acute Renal Failure in Critically Ill Patients: Current Evidence-Based Practices.危重症患者的急性肾衰竭:当前基于证据的实践
R I Med J (2013). 2019 Dec 2;102(10):22-25.
6
[Renal replacement therapy in the intensive care unit].[重症监护病房中的肾脏替代治疗]
Anaesthesist. 2006 Aug;55(8):901-13; quiz 914. doi: 10.1007/s00101-006-1071-y.
7
Red blood cell distribution width is an independent predictor of mortality in acute kidney injury patients treated with continuous renal replacement therapy.红细胞分布宽度是连续性肾脏替代治疗急性肾损伤患者死亡率的独立预测因子。
Nephrol Dial Transplant. 2012 Feb;27(2):589-94. doi: 10.1093/ndt/gfr307. Epub 2011 Jun 28.
8
Outcomes in critically ill patients with hematologic malignancies who received renal replacement therapy for acute kidney injury in an intensive care unit.重症监护病房中接受肾脏替代治疗的血液恶性肿瘤危重症患者的急性肾损伤结局。
J Crit Care. 2011 Feb;26(1):107.e1-6. doi: 10.1016/j.jcrc.2010.07.006. Epub 2010 Sep 1.
9
The intensive care medicine agenda on acute kidney injury.重症医学与急性肾损伤。
Intensive Care Med. 2017 Sep;43(9):1198-1209. doi: 10.1007/s00134-017-4687-2. Epub 2017 Jan 30.
10
Comparison of two strategies for initiating renal replacement therapy in the intensive care unit: study protocol for a randomized controlled trial (AKIKI).重症监护病房中启动肾脏替代治疗的两种策略比较:一项随机对照试验(AKIKI)的研究方案
Trials. 2015 Apr 17;16:170. doi: 10.1186/s13063-015-0718-x.

引用本文的文献

1
Predictive Factors for the Discontinuation of Renal Replacement Therapy in Critically Ill Adults: A Systematic Review and Meta-Analysis.危重症成年患者停止肾脏替代治疗的预测因素:一项系统评价和荟萃分析
Cureus. 2025 Apr 6;17(4):e81783. doi: 10.7759/cureus.81783. eCollection 2025 Apr.
2
Sepsis, Management & Advances in Metabolomics.脓毒症:代谢组学的管理与进展。
Nanotheranostics. 2024 Feb 25;8(3):270-284. doi: 10.7150/ntno.94071. eCollection 2024.
3
Improving Outcomes in Hepatorenal Syndrome-Acute Kidney Injury With Early Diagnoses and Implementation of Approved Treatment Regimens.
通过早期诊断和实施批准的治疗方案改善肝肾综合征-急性肾损伤的治疗效果。
Gastroenterol Hepatol (N Y). 2023 Dec;19(12 Suppl 7):3-13.
4
Development and validation of a nomogram to predict the risk of renal replacement therapy among acute kidney injury patients in intensive care unit.建立并验证一个列线图模型,用于预测 ICU 急性肾损伤患者接受肾脏替代治疗的风险。
Clin Exp Nephrol. 2023 Nov;27(11):951-960. doi: 10.1007/s10157-023-02383-5. Epub 2023 Jul 27.
5
The Current Management of Hepatorenal Syndrome-Acute Kidney Injury in the United States and the Potential of Terlipressin.肝肾综合征-急性肾损伤的美国现行管理及特利加压素的潜力
Liver Transpl. 2021 Aug;27(8):1191-1202. doi: 10.1002/lt.26072. Epub 2021 Jul 14.